Implementations by Phenotype

Title Phenotypesort descending Institution Algorithm Type Total Cases Total Controls PPV Sensitivity
Appendicitis Implementation - Columbia Appendicitis Columbia University Case, Control 21 3,038
Vanderbilt March 2016 Appendicitis Vanderbilt University Medical Center Case, Control
appendicitis CHOP eMERGE III Appendicitis CHOP Case, Control
Harvard Implementation Appendicitis Case, Control 877 771
GH/UW Implementation Appendicitis Case, Control 0 1,761
NU appendicitis cases Appendicitis Northwestern University Case Only 30 100%
Appendicitis Case 1, Control Appendicitis Cincinnati Children's Hospital Medical Center Case, Control 15 20 93%, 100%
Appendicitis Case 2-MED Appendicitis Cincinnati Children's Hospital Medical Center Case Only 90%
CHOP implementation Case 1 and Controls Appendicitis CHOP Case, Control 86%, 100%
CHOP implementation Case 2 Appendicitis CHOP Case Only 2 50%
Sleep Apnea-Columbia Sleep Apnea Phenotype Columbia University Case Only
Validation on 75 RA patients Identification of Fibromyalgia Patients in a Rheumatoid Arthritis Cohort Vanderbilt University Case Only 97%
Fibromyalgia in Rheumatoid Arthritis-Columbia Identification of Fibromyalgia Patients in a Rheumatoid Arthritis Cohort Columbia University Case Only
Healthy Weight-Columbia MidSouth CDRN - Healthy Weight Algorithm Columbia University Case Only
CCHMC - PART 1 Epilepsy/Antiepileptic drug response algorithm Cincinnati Children's Hospital Medical Center Case Only 129 86%
Epilepsy Part I - Columbia Epilepsy/Antiepileptic drug response algorithm Columbia University Case, Control 2 244
Geisinger Implementation Epilepsy/Antiepileptic drug response algorithm Geisinger Case, Control 61 6,414
Epilepsy Phenotype Case and Control Epilepsy/Antiepileptic drug response algorithm KPWHRI Case, Control 23 3,282
CHOP Part I Epilepsy/Antiepileptic drug response algorithm CHOP Case, Control 92%
CHOP Part II- NONRESPONDERS Epilepsy/Antiepileptic drug response algorithm CHOP Case Only 85%
CHOP Part II- RESPONDERS Epilepsy/Antiepileptic drug response algorithm Case Only 85%
Group Health/University of Washington CRC Validation Colorectal Cancer (CRC) GH/UW Case, Control 25 25 92%, 100% 100%, 100%
Northwestern University Validation Colorectal Cancer (CRC) Northwestern University Case, Control 50 50 86%, 98% 92%
Harvard CRC Implementation Colorectal Cancer (CRC) Harvard Medical School Case, Control 95 10,388
Geisinger Impl Colorectal Cancer (CRC) Geisinger Case, Control 25 25 100%, 100%

Pages